恒瑞125亿美元、石药超20亿美元小分子对外授权;赛诺菲、BMS又有新动态... | 一周交易

创鉴汇
Aug 07

据创鉴汇不完全统计,7月28日至8月3日全球生物制药领域共披露25起交易事件,潜在交易总额近190亿美元。交易类型涵盖药物授权、合作研发、资产收购和企业并购等形式。从交易内容来看,小分子药物、抗体、RNAi和细胞疗法等热度不减。上周两起小分子对外授权案例引人注目。7月28日,恒瑞医药宣布和GSK达成协议,以潜在总额125亿美元(包括5亿美元首付款)将HRS-9821和至多11个项目授权给后者。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10